Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2001 1
2002 1
2003 1
2004 1
2006 2
2008 1
2009 1
2011 4
2012 4
2013 3
2014 1
2015 2
2016 3
2017 6
2018 1
2019 1
2020 2
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.
Gato-Cañas M, Zuazo M, Arasanz H, Ibañez-Vea M, Lorenzo L, Fernandez-Hinojal G, Vera R, Smerdou C, Martisova E, Arozarena I, Wellbrock C, Llopiz D, Ruiz M, Sarobe P, Breckpot K, Kochan G, Escors D. Gato-Cañas M, et al. Among authors: arozarena i. Cell Rep. 2017 Aug 22;20(8):1818-1829. doi: 10.1016/j.celrep.2017.07.075. Cell Rep. 2017. PMID: 28834746 Free article.
Overcoming resistance to BRAF inhibitors.
Arozarena I, Wellbrock C. Arozarena I, et al. Ann Transl Med. 2017 Oct;5(19):387. doi: 10.21037/atm.2017.06.09. Ann Transl Med. 2017. PMID: 29114545 Free PMC article. Review.
Targeting invasive properties of melanoma cells.
Arozarena I, Wellbrock C. Arozarena I, et al. FEBS J. 2017 Jul;284(14):2148-2162. doi: 10.1111/febs.14040. Epub 2017 Mar 1. FEBS J. 2017. PMID: 28196297 Free article. Review.
Targeting MITF in the tolerance-phase.
Arozarena I, Smith MP, Wellbrock C. Arozarena I, et al. Oncotarget. 2016 Aug 23;7(34):54094-54095. doi: 10.18632/oncotarget.9423. Oncotarget. 2016. PMID: 27528022 Free PMC article. No abstract available.
Cooperative behaviour and phenotype plasticity evolve during melanoma progression.
Rowling EJ, Miskolczi Z, Nagaraju R, Wilcock DJ, Wang P, Telfer B, Li Y, Lasheras-Otero I, Redondo-Muñoz M, Sharrocks AD, Arozarena I, Wellbrock C. Rowling EJ, et al. Among authors: arozarena i. Pigment Cell Melanoma Res. 2020 Sep;33(5):695-708. doi: 10.1111/pcmr.12873. Epub 2020 Mar 20. Pigment Cell Melanoma Res. 2020. PMID: 32145051 Free PMC article.
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
Viúdez A, Crespo G, Gómez Dorronsoro ML, Arozarena I, Marín-Méndez JJ, Custodio A, Benavent M, Goñi S, García-Paredes B, Hernando J, Durantez M, Alonso V, Riesco MDC, López C, Jiménez-Fonseca P, San Vicente BL, González-Borja I, Sevilla I, Hernández-Garcia I, Carmona-Bayonas A, Capdevila J, Pérez-Sanz J, García-Carbonero R, Pérez-Ricarte L, Llanos M, Vera R, De Jesús Acosta A. Viúdez A, et al. Among authors: arozarena i. Pancreatology. 2021 Jan;21(1):215-223. doi: 10.1016/j.pan.2020.12.009. Epub 2020 Dec 19. Pancreatology. 2021. PMID: 33358592
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure.
Smith MP, Rowling EJ, Miskolczi Z, Ferguson J, Spoerri L, Haass NK, Sloss O, McEntegart S, Arozarena I, von Kriegsheim A, Rodriguez J, Brunton H, Kmarashev J, Levesque MP, Dummer R, Frederick DT, Andrews MC, Cooper ZA, Flaherty KT, Wargo JA, Wellbrock C. Smith MP, et al. Among authors: arozarena i. EMBO Mol Med. 2017 Aug;9(8):1011-1029. doi: 10.15252/emmm.201607156. EMBO Mol Med. 2017. PMID: 28606996 Free PMC article.
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page